Join the 7th Annual OTC Derivatives summit to discuss:
Regulations
- Extra territoriality of new regulations and the interactions between them
- The impact of the current changes on pension-funds
CCPs
- How does the new execution environment affect the buy-side
- What should you consider when choosing your clearing member?
- Investigating the new commercial model for clearers with regards to the initial margin
- Challenge of portability and segregation under the new regime
Pricing and valuation
- Best practice in valuation from a buy and a sell side perspective
- How can the front, middle, and back offices work together to effectively price?
Collateral Management
- What is eligible collateral and how can you ensure its availability?
- Changing legal documentation that you should provide in collateral management
- What are your collateral transformation options?
Operational Optimisation
- Outsourcing or in-house – which is best for your operational structure?
- Benefits of homogenisation and consolidation
Chairing the event:
Bill Hodgson,Owner,The OTC Space
Bauke Vriesema,Consultant,
Voogt Pijl & Partners
Featured Speakers:
Steve Maton, Head of Middle Office, Legal & General Investment Management
John Wilson, Former Global Lead, OTC Client Clearing at RBS
Nicole Grootveld-Sandig, COO Cardano NL, Cardano
Florian Stärk, Head of Risk Controlling, MEAG Munich ERGO Asset Management GmbH
Alastair Thomas, Head of Market Risk and Treasury ManagementEuropean Credit Management
Jez Bezant, Independent Consultant
Martin Higgs, Senior Vice President, State Street Bank & Trust Company
Andy Ross, European Head of OTC Clearing, Morgan Stanley
Paul Kat, Senior Legal Counsel, Robeco
Guy Usher, Head of Derivatives & Structured, Finance Field Fisher Waterhouse LLP
Anthony Kirby, Director Regulatory Risk Management, Ernst & Young LLP
Terence Nahar, Head of Derivatives, Scottish Widows Investment Partnership
